PMID- 16670831
OWN - NLM
STAT- MEDLINE
DCOM- 20070731
LR  - 20211020
IS  - 0770-3198 (Print)
IS  - 0770-3198 (Linking)
VI  - 26
IP  - 6
DP  - 2007 Jun
TI  - Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus 
      erythematosus: a possible alternative.
PG  - 981-3
AB  - Subacute cutaneous lupus erythematosus (SCLE) is a common manifestation of 
      systemic lupus erythematosus. In many cases it appears to be resistant to various 
      systemic or topical treatments. Three cases of resistant SCLE with good response 
      to intravenous immunoglobulin (IVIG) are described here suggesting that IVIG 
      could be an alternative treatment in these patients.
FAU - Lampropoulos, Christos E
AU  - Lampropoulos CE
AD  - The Louise Coote Lupus Unit, The Rayne Institute, St. Thomas' Hospital, 4 Lambeth 
      Palace Road, London, SE1 7EH, UK.
FAU - Hughes, Graham R V
AU  - Hughes GR
FAU - D' Cruz, David P
AU  - D' Cruz DP
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20060503
PL  - Germany
TA  - Clin Rheumatol
JT  - Clinical rheumatology
JID - 8211469
RN  - 0 (Immunoglobulins, Intravenous)
RN  - 0 (Immunologic Factors)
SB  - IM
MH  - Adult
MH  - Female
MH  - Humans
MH  - Immunoglobulins, Intravenous/*therapeutic use
MH  - Immunologic Factors/*therapeutic use
MH  - Lupus Erythematosus, Discoid/*drug therapy
MH  - Treatment Outcome
EDAT- 2006/05/04 09:00
MHDA- 2007/08/01 09:00
CRDT- 2006/05/04 09:00
PHST- 2006/01/17 00:00 [received]
PHST- 2006/01/18 00:00 [accepted]
PHST- 2006/05/04 09:00 [pubmed]
PHST- 2007/08/01 09:00 [medline]
PHST- 2006/05/04 09:00 [entrez]
AID - 10.1007/s10067-006-0222-5 [doi]
PST - ppublish
SO  - Clin Rheumatol. 2007 Jun;26(6):981-3. doi: 10.1007/s10067-006-0222-5. Epub 2006 
      May 3.